Abstract

Evaluation of the Physicochemical Stability of Amiodarone Hydrochloride in Syringes for the Intensive Care Unit

Author(s): Lardinois Benjamin, Dimitriou Alexandre, Delcave Charlotte, Jamart Jacques, Bihin Benoît, Soumoy Laura, Hecq Jean-Daniel, Galanti Laurence M

Issue: Mar/Apr 2019 - Volume 23, Number 2

Page(s): 163-166

Download in electronic PDF format for $75
  • Evaluation of the Physicochemical Stability of Amiodarone Hydrochloride in Syringes for the Intensive Care Unit Page 1
  • Evaluation of the Physicochemical Stability of Amiodarone Hydrochloride in Syringes for the Intensive Care Unit Page 2
  • Evaluation of the Physicochemical Stability of Amiodarone Hydrochloride in Syringes for the Intensive Care Unit Page 3
  • Evaluation of the Physicochemical Stability of Amiodarone Hydrochloride in Syringes for the Intensive Care Unit Page 4

Abstract

In some emergency clinical situations, the injection of a more concentrated drug solution in the intensive care units is common. The purpose of this study was to evaluate the physicochemical stability of concentrated solutions of amiodarone hydrochloride in polypropylene syringes during 28 days of storage at 5°C ± 3°C, with protection from light. Five syringes of 50 mL, containing 25 mg/mL of amiodarone in dextrose 5%, were prepared and stored at 5°C ± 3°C with protection from light during 28 days. Immediately after preparation and periodically during the storage, amiodarone hydrochloride concentrations were measured by ultra-performance liquid chromatography. Spectrophotometric absorbance at different wavelengths, pH measurement, and microscopic observations were also performed. All solutions were physicochemically stable during the study period when stored at 5°C ± 3°C. No color change, turbidity, precipitation, opacity, significant pH variations, or optic densities were observed in the solutions. No crystals were seen by microscopic analysis. The concentration of amiodarone did not decrease during the 28 days of storage. Solutions of amiodarone 25 mg/mL in syringes of dextrose 5% are physically and chemically stable for at least 28 days when stored in syringes at 5°C ± 3°C with protection from light and may be prepared in advanced by a centralized intravenous additive service.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy
Title/Author
(Click for Abstract / Details / Purchase)
Mar/Apr 2019
Pg. 163-166
Sep/Oct 2003
Pg. 389-393
Jul/Aug 2019
Pg. 320-323
Jul/Aug 2018
Pg. 335-339
Jul/Aug 2016
Pg. 328-332
Jan/Feb 2020
Pg. 64-68
Jan/Feb 2002
Pg. 66-69
Jan/Feb 2002
Pg. 70-73
Jan/Feb 2002
Pg. 74-76
Sep/Oct 2019
Pg. 434-437
Sep/Oct 2014
Pg. 427-431
Sep/Oct 1997
Pg. 347-348
Author(s): Pramar Yashoda V
May/Jun 2003
Pg. 170-174
Author(s): Meece Jerry
May/Jun 2004
Pg. 228-230
Jul/Aug 2017
Pg. 322-329
Mar/Apr 2019
Pg. 157-162
Mar/Apr 2020
Pg. 156-162
Jul/Aug 2022
Pg. 342-351
Jul/Aug 2022
Pg. 330-335
May/Jun 2022
Pg. 248-254